High	O
-	O
mobility	O
group	O
A2	O
protein	O
modulates	O
hTERT	O
transcription	O
to	O
promote	O
tumorigenesis	O
.	O

The	O
high	O
-	O
mobility	O
group	O
A2	O
gene	O
(	O
HMGA2	O
)	O
is	O
one	O
of	O
the	O
most	O
frequently	O
amplified	O
genes	O
in	O
human	O
cancers	B-Cancer
.	O

However	O
,	O
functions	O
of	O
HMGA2	O
in	O
tumorigenesis	O
are	O
not	O
fully	O
understood	O
due	O
to	O
limited	O
knowledge	O
of	O
its	O
targets	O
in	O
tumor	B-Cell
cells	I-Cell
.	O

Our	O
study	O
reveals	O
a	O
novel	O
link	O
between	O
HMGA2	O
and	O
the	O
regulation	O
of	O
human	O
telomerase	O
reverse	O
transcriptase	O
(	O
hTERT	O
)	O
,	O
the	O
catalytic	O
subunit	O
of	O
telomerase	O
,	O
which	O
offers	O
critical	O
insight	O
into	O
how	O
HMGA2	O
contributes	O
to	O
tumorigenesis	O
.	O

The	O
expression	O
of	O
HMGA2	O
modulates	O
the	O
expression	O
of	O
hTERT	O
,	O
resulting	O
in	O
cells	B-Cell
with	O
enhanced	O
telomerase	O
activities	O
and	O
increased	O
telomere	B-Cellular_component
length	O
.	O

Treatment	O
with	O
suberoylanilide	O
hydroxamide	O
(	O
SAHA	O
)	O
,	O
a	O
histone	O
deacetylase	O
(	O
HDAC	O
)	O
inhibitor	O
,	O
causes	O
dose	O
-	O
dependent	O
hTERT	O
reporter	O
activation	O
,	O
mimicking	O
HMGA2	O
overexpression	O
.	O

By	O
interacting	O
with	O
Sp1	O
,	O
HMGA2	O
interferes	O
with	O
the	O
recruitment	O
of	O
HDAC2	O
to	O
the	O
hTERT	O
proximal	O
promoter	O
,	O
enhancing	O
localized	O
histone	O
H3	O
-	O
K9	O
acetylation	O
and	O
thereby	O
stimulating	O
hTERT	O
expression	O
and	O
telomerase	O
activity	O
.	O

Moreover	O
,	O
HMGA2	O
knockdown	O
by	O
short	O
hairpin	O
HMGA2	O
in	O
HepG2	B-Cell
cells	I-Cell
leads	O
to	O
progressive	O
telomere	B-Cellular_component
shortening	O
and	O
a	O
concurrent	O
decrease	O
of	O
steady	O
-	O
state	O
hTERT	O
mRNA	O
levels	O
,	O
attenuating	O
their	O
ability	O
to	O
form	O
colonies	B-Cell
in	O
soft	O
agar	O
.	O

Importantly	O
,	O
HMGA2	O
partially	O
replaces	O
the	O
function	O
of	O
hTERT	O
during	O
the	O
tumorigenic	O
transformation	O
of	O
normal	O
human	O
fibroblasts	B-Cell
.	O

These	O
findings	O
are	O
potentially	O
clinically	O
relevant	O
,	O
because	O
HMGA2	O
expression	O
is	O
reported	O
to	O
be	O
upregulated	O
in	O
a	O
number	O
of	O
human	O
cancers	B-Cancer
as	O
telomere	B-Cellular_component
maintenance	O
is	O
essential	O
for	O
tumorigenesis	O
.	O

